Filtering by:
Skin CancerHow to Spot Skin Cancer
Skin cancer is by far the most common type of cancer. If you know what to look for, you can spot warning signs of skin cancer early.
Melanoma Survivor Focuses on Fitness and Health
For Tarik Ceric, competing in a body building contest while in cancer treatment is one of the toughest things he’s ever done – and also one of the most rewarding.
Study: Lack of Education About Melanoma May Contribute to Black-White Survival Disparities
t’s true that people with darker skin have a lower risk of melanoma. But as a recent study showed, it’s also true that non-Hispanic black Americans are more likely to have lower survival rates when they are diagnosed. That’s partly because compared with non-Hispanic whites, people with darker skin are more often diagnosed with later-stage melanoma (after it’s spread). It’s also because the most common type of melanoma among non-Hispanic blacks—called acral lentiginous melanoma (ALM)—has a lower survival rate.
Are You Getting Enough Vitamin D?
Our bodies need vitamin D for healthy bones. And some studies suggest it may be linked with lower colorectal cancer risk. Find out how much vitamin D you need and how to get it safely.
FDA Approves Libtayo (Cemiplimab) for a Type of Skin Cancer
The US Food and Drug Administration (FDA) has approved Libtayo (cemiplimab) to treat people with advanced squamous cell carcinoma of the skin.
Melanoma and Thyroid Cancer Survivor Has Inherited Syndrome
Cowden disease is a type of PTEN hamartoma tumor syndrome (PHTS) caused by a mutation in the PTEN gene. PHTS raises the risk of developing certain types of cancer, including skin, thyroid, breast, endometrial, colorectal, and kidney.
Microorganisms Living on Your Skin May Relate to Skin Cancer Risk
The viruses, fungi, and bacteria on your skin could provide clues for skin cancer development and treatment.
FDA Approves Keytruda (Pembrolizumab) for Any Tumor with Specific Genetic Change
The US Food and Drug Administration (FDA) has expanded the approval of the immunotherapy drug Keytruda (pembrolizumab) to include tumors with a specific genetic change regardless of cancer type.
